Interestingly, miR-484 in OC cells directly regulates VEGFB protein on tumor cells or inhibits the receptor VEGFR2 targeting VEGF signaling pathway on tumor-associated endothelial cells in a paracrine manner to control angiogenesis, leading to normalization of tumor microenvironment and enhanced drug sensitivity (46) (Table 3). The gene discussed is KDR; the disease is neoplasm.